Joseph Limber Biography and Net Worth

Director of XOMA Royalty

Joseph M. Limber has been a director since December 2012. Mr. Limber was President and Chief Executive Officer and a member of the Board of Secura Bio, Inc., from 2019-2024. Prior to that, Mr. Limber served as President and Chief Executive Officer of Genoptix, Inc. from March 2017 through December 2018. Mr. Limber served as Executive Chairman of ImaginAb from January 2016 through November 2017. Mr. Limber served as President and Chief Executive Officer of Gradalis, Inc. from July 2013 through April 2015. Mr. Limber served as President and Chief Executive Officer of Prometheus Laboratories Inc., a subsidiary of Nestlé Health Science, from December 2003 through April 2013 and as a member of its Board from January 2004 through April 2013. From January 2003 to July 2003, Mr. Limber was a consultant and interim Chief Executive Officer for Deltagen, Inc., a provider of drug discovery tools and services to the biopharmaceutical industry. From April 1998 to December 2002, Mr. Limber was the President and Chief Executive Officer of ACLARA BioSciences, Inc. (now Monogram Biosciences, Inc.), a developer of assay technologies and lab-ona-chip systems for life science research. From 1996 to 1998, he was the President and Chief Operating Officer of Praecis Pharmaceuticals, Inc. (acquired by GlaxoSmithKline plc), a biotechnology company focused on the discovery and development of pharmaceutical products. Prior to Praecis, Mr. Limber served as Executive Vice President of SEQUUS Pharmaceuticals, Inc. (acquired by Alza Corporation and now part of the Johnson & Johnson family of companies). He also held management positions in marketing and sales with Syntex Corporation (now F. Hoffmann-La Roche Ltd.) and with Ciba-Geigy Corporation (now Novartis AG). Mr. Limber holds a B.A. from Duquesne University. Mr. Limber brings to the Board his experience in successfully developing markets for specialty pharmaceutical products and managing the critical transition from research organization to commercial entity.

What is Joseph M. Limber's net worth?: The estimated net worth of Joseph M. Limber is at least $514.39 thousand as of April 3rd, 2025. Mr. Limber owns 16,524 shares of XOMA Royalty stock worth more than $514,392 as of December 4th. This net worth approximation does not reflect any other investments that Mr. Limber may own. Learn More about Joseph M. Limber's net worth.
How do I contact Joseph M. Limber?: The corporate mailing address for Mr. Limber and other XOMA Royalty executives is 2200 POWELL STREET SUITE 310, EMERYVILLE CA, 94608. XOMA Royalty can also be reached via phone at (510) 204-7200 and via email at [email protected]. Learn More on Joseph M. Limber's contact information.
Has Joseph M. Limber been buying or selling shares of XOMA Royalty?: Joseph M. Limber has not been actively trading shares of XOMA Royalty during the last quarter. Most recently, on Monday, April 7th, Joseph M. Limber bought 5,243 shares of XOMA Royalty stock. The stock was acquired at an average cost of $25.60 per share, with a total value of $134,220.80. Following the completion of the transaction, the director now directly owns 10,000 shares of the company's stock, valued at $256,000. Learn More on Joseph M. Limber's trading history.
Who are XOMA Royalty's active insiders?: XOMA Royalty's insider roster includes Owen Hughes (CEO), Joseph Limber (Director), James Neal (CEO), and Bradley Sitko (Chief Investment Officer). Learn More on XOMA Royalty's active insiders.
Are insiders buying or selling shares of XOMA Royalty?: In the last year, XOMA Royalty insiders bought shares 6 times. They purchased a total of 29,925 shares worth more than $750,844.26. In the last year, insiders at the biotechnology company sold shares 4 times. They sold a total of 923,432 shares worth more than $24,518,663.26. The most recent insider tranaction occured on September, 22nd when CFO Thomas M Burns sold 4,330 shares worth more than $155,836.70. Insiders at XOMA Royalty own 9.1% of the company. Learn More about insider trades at XOMA Royalty.
Information on this page was last updated on 9/22/2025.

Joseph M. Limber Insider Trading History at XOMA Royalty

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/7/2025	Buy	5,243	$25.60	$134,220.80	10,000
4/3/2025	Buy	17,935	$25.24	$452,679.40	16,524

Joseph M. Limber Buying and Selling Activity at XOMA Royalty

XOMA Royalty Company Overview

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Today's Range

Now: $31.13

$30.31

$31.44

50 Day Range

MA: $34.36

$29.76

$39.72

2 Week Range

Now: $31.13

$18.35

$39.92

Volume

37,551 shs

Average Volume

56,321 shs

Market Capitalization

$385.39 million

P/E Ratio

42.07

Dividend Yield

N/A

Beta

0.94